Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003985676 | SCV004796945 | likely pathogenic | CACNA1A-related disorder | 2024-02-26 | no assertion criteria provided | clinical testing | The CACNA1A c.4470C>A variant is predicted to result in premature protein termination (p.Tyr1490*). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. A downstream frameshift variant leading to protein truncation or nonsense mediated decay (p.Pro2052fs) has been reported in patients with episodic ataxia type 2 (Jen et al. 2004. PubMed ID: 14718690). Nonsense variants in CACNA1A are expected to be pathogenic. This variant is interpreted as likely pathogenic. |